Exagen to Announce Second Quarter Financial Results on August 4, 2026
Exagen Inc., a Nasdaq-listed company specializing in autoimmune diagnostics, announced it will report its financial results for the quarter ending June 30, 2026, on August 4, 2026, before market open. The company will host a conference call led by its CEO and CFO to discuss the results, providing updates on its innovative autoimmune testing portfol…